Utility of tumour markers in the diagnosis of neoplastic pleural effusion

作者: M.Esther San Jose , David Alvarez , Luis Valdes , Alfredo Sarandeses , Jose Manuel Valle

DOI: 10.1016/S0009-8981(97)00120-4

关键词:

摘要: Abstract Approximately 20% of pleural effusions are caused by neoplastic processes. Although cytology is the most specific routine diagnostic procedure, its sensitivity 50–60% insufficient, and thus diagnosis usually carried out more invasive techniques such as biopsy, thoracoscopy or thoracotomy. The object this study to evaluate use determining some tumour markers in fluid obtained thoracocentesis for effusion. Patients (271) with were classified five groups: I: neoplasms n = 88; II: tuberculosis 63; III: parapneumonics 53; IV: miscellaneous exudates 39 V: transudates 28. studied were: carcinoembryonic antigen (CEA), CA 125, squamous cell carcinoma (SCC), neuron enolase (NSE). makers had following efficiencies origin effusion: CEA 76% (sensitivity 31%, specificity 93%); 125 66% (70% 61%); SCC 65% (48% 80%) NSE 53% (30% 89%). pulmonary origins 68% 83%, 53%); (54% 75%); 63% (80% 48%) 61% (79% 42%). We believe that testing would greatly increase effectiveness could avoid practice aggressive on patient.

参考文章(18)
Beck, Shultz Ek, The use of relative operating characteristic (ROC) curves in test performance evaluation. Archives of Pathology & Laboratory Medicine. ,vol. 110, pp. 13- 20 ,(1986)
K. Kandylis, M. Vassilomanolakis, N. Baziotis, A. Papadimitriou, S. Tsoussis, A. Ferderigou, A.P. Efremidis, Diagnostic significance of the tumour markers CEA, CA 15–3 and CA 125 in malignant effusions in breast cancer Annals of Oncology. ,vol. 1, pp. 435- 438 ,(1990) , 10.1093/OXFORDJOURNALS.ANNONC.A057798
Shinsuke Tamura, Tetsuya Nishigaki, Yuji Moriwaki, Hiroshi Fujioka, Takashi Nakano, Junji Fujii, Tetsuya Yamamoto, Kenji Nabeshima, Toshikazu Hada, Kazuya Higashino, Tumor markers in pleural effusion diagnosis Cancer. ,vol. 61, pp. 298- 302 ,(1988) , 10.1002/1097-0142(19880115)61:2<298::AID-CNCR2820610219>3.0.CO;2-U
Semra Paydaş, Özoĝul Sargin, Süleyman Özbek, Elif Gürbüz, Ferritin levels in malignant effusions: a useful marker? European Journal of Cancer and Clinical Oncology. ,vol. 26, pp. 919- ,(1990) , 10.1016/0277-5379(90)90202-5
Phil Gold, Samuel O. Freedman, DEMONSTRATION OF TUMOR-SPECIFIC ANTIGENS IN HUMAN COLONIC CARCINOMATA BY IMMUNOLOGICAL TOLERANCE AND ABSORPTION TECHNIQUES Journal of Experimental Medicine. ,vol. 121, pp. 439- 462 ,(1965) , 10.1084/JEM.121.3.439
J. Mezger, A. Calavrezos, P. Drings, U. Gatzemeier, E. Kaukel, N. Konietzko, G. Koschel, R. Lamerz, J.v. Pawel, W. R�mer, Value of serum and effusion fluid CEA levels for distinguishing between diffuse malignant mesothelioma and carcinomatous pleural metastases Lung. ,vol. 172, pp. 183- 184 ,(1994) , 10.1007/BF00175946
Lewis J. Wesselius, Diana S. Dark, Christopher J. Papasian, Airway carcinoembryonic antigen concentrations in patients with central lung cancer or chronic bronchitis. Chest. ,vol. 98, pp. 393- 397 ,(1990) , 10.1378/CHEST.98.2.393
P. Ferroni, C. Szpak, J. W. Greiner, J. F. Simpson, F. Guadagni, W. W. Johnston, D. Colcher, CA 72-4 radioimmunoassay in the diagnosis of malignant effusions. Comparison of various tumor markers. International Journal of Cancer. ,vol. 46, pp. 445- 451 ,(1990) , 10.1002/IJC.2910460320